Detalles de la búsqueda
1.
Incidence of primary hepatitis C infection among people who inject drugs during 2012-2020 in Athens, Greece.
J Viral Hepat
; 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38742938
2.
HERACLIS-HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg-positive patients.
Liver Int
; 43(9): 1879-1889, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37288712
3.
Significance of serum HBV RNA in non-cirrhotic HBeAg-negative chronic hepatitis B patients who discontinue effective antiviral therapy.
J Viral Hepat
; 29(11): 948-957, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35789515
4.
Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg-negative chronic hepatitis B.
J Viral Hepat
; 27(2): 118-126, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562748
5.
Evaluation of the effectiveness of eight screening tools in detecting risk of malnutrition in cirrhotic patients: the KIRRHOS study.
Br J Nutr
; 122(12): 1368-1376, 2019 12 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31735186
6.
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.
J Hepatol
; 68(6): 1129-1136, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29427727
7.
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B.
Hepatology
; 66(5): 1444-1453, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28622419
8.
Discontinuation of oral antivirals in chronic hepatitis B: A systematic review.
Hepatology
; 63(5): 1481-92, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27100145
9.
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy.
J Hepatol
; 64(4): 800-6, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26678008
10.
High levels of all-cause mortality among people who inject drugs from 2018 to 2022.
Int J Drug Policy
; 126: 104356, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38394950
11.
The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver Cirrhosis.
J Clin Med
; 12(9)2023 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37176772
12.
Validation of cutoffs for skeletal muscle mass index based on computed tomography analysis against dual energy X-ray absorptiometry in patients with cirrhosis: the KIRRHOS study.
Ann Gastroenterol
; 33(1): 80-86, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31892802
13.
Changes in serum transforming growth factor-ß1 levels in chronic hepatitis C patients under antiviral therapy.
Ann Gastroenterol
; 29(1): 79-84, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26752952
14.
Reliability and applicability of two-dimensional shear-wave elastography for the evaluation of liver stiffness.
Eur J Gastroenterol Hepatol
; 28(10): 1204-9, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27340898
15.
Bravo 48-hour Wireless pH Monitoring in Patients With Non-cardiac Chest Pain. Objective Gastroesophageal Reflux Disease Parameters Predict the Responses to Proton Pump Inhibitors.
J Neurogastroenterol Motil
; 18(2): 169-73, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22523725
Resultados
1 -
15
de 15
1
Próxima >
>>